NG
Therapeutic Areas
Akebia Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Vadadustat | Anemia due to Chronic Kidney Disease (CKD) | Phase 3 |
| Undisclosed HIF-PHI Programs | Anemia due to CKD and other potential indications | Research / Discovery |
| FDA-approved Product 1 | Complications of Kidney Disease | Approved |
| FDA-approved Product 2 | Complications of Kidney Disease | Approved |
Leadership Team at Akebia Therapeutics
JB
John Butler
President and Chief Executive Officer
MB
Meredith Bowman
Senior Vice President, Chief People Officer
SK
Steven K. Burke, M.D.
Senior Vice President, Chief Research & Development Officer
JM
Justin McCue, Ph.D.
Senior Vice President, Chief Technology Officer
EO
Erik Ostrowski
Senior Vice President, Chief Financial Officer and Chief Business Officer
CR
Carolyn Rucci
Senior Vice President, Chief Legal Officer & Secretary
AA
Adrian Adams
Chairperson of the Board of Directors